CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0%

Compliant submissions 0

Incompliant submissions 0

Total trials 0

My Organizations' Clinical Trials

Showing 150 of 434 entries

View as:

Special Investigation For Long-Term Use Of Sildenafil (Regulatory Post Marketing Commitment Plan)

Phase: N/A Priority: Normal

NCT ID: NCT00666198 Org: User:

Start: 05/31/08 End: 06/30/15 Due: 06/30/16

A Post Marketing Surveillance Study Of Doxazosin Mesylate GITS Among Filipino Patients With Benign Prostatic Hyperplasia (BPH)

Phase: N/A Priority: Normal

NCT ID: NCT01003886 Org: User:

Start: 05/31/09 End: 01/31/11 Due: 01/31/12

Safety, Tolerability, and Pharmacokinetic Study of Pregabalin in Pediatric Patients With Partial Onset Seizures

Phase: N/A Priority: Normal

NCT ID: NCT00437281 Org: User:

Start: 04/30/07 End: 11/30/12 Due: 11/30/13

Effectiveness Of A Program That Includes Counseling And Patient Support On Adherence To Treatment With Lipitor

Phase: N/A Priority: Normal

NCT ID: NCT01078285 Org: User:

Start: 03/31/10 End: 11/30/11 Due: 11/30/12

Evaluation Of Sperm Production With Healthy Male Volunteers Receiving Lyrica Or Placebo

Phase: N/A Priority: Normal

NCT ID: NCT00631696 Org: User:

Start: 02/29/08 End: 02/29/12 Due: 02/28/13

Safety And Efficacy Of Sildenafil In Children With Pulmonary Arterial Hypertension

Phase: N/A Priority: Normal

NCT ID: NCT01642407 Org: User:

Start: 08/24/12 End: 03/12/18 Due: 03/12/19

One-Year Trial of Oral Ziprasidone in Bipolar Patients With Metabolic Syndrome

Phase: N/A Priority: Normal

NCT ID: NCT01113541 Org: User:

Start: 07/31/10 End: 02/28/11 Due: 02/28/12

Examination of Pregabalin Access for Treatment of Indicated Pain Disorders: the ExPAND Study

Phase: N/A Priority: Normal

NCT ID: NCT01280747 Org: User:

Start: 01/31/11 End: 04/30/12 Due: 04/30/13

A Post Marketing Surveillance Study On Pregabalin (Lyrica) On Efficacy, Safety And Tolerability Of Pregabalin

Phase: N/A Priority: Normal

NCT ID: NCT00892008 Org: User:

Start: 09/30/06 End: 08/31/08 Due: 08/31/09

Comparison of Pregabalin Versus Venlafaxine XR and Placebo in the Treatment of Generalized Anxiety Disorder

Phase: N/A Priority: Normal

NCT ID: NCT00151450 Org: User:

Start: 03/31/05 End: 11/30/06 Due: 11/30/07

A Study Of Sertraline Compared With Paroxetine In The Treatment Of Panic Disorder

Phase: N/A Priority: Normal

NCT ID: NCT00677352 Org: User:

Start: 05/31/08 End: 02/28/10 Due: 02/28/11

A Study of the Safety and Tolerability of Oral Ziprasidone in Children and Teens With Psychotic Disorders

Phase: N/A Priority: Normal

NCT ID: NCT00650611 Org: User:

Start: 12/31/03 End: 03/31/05 Due: 03/31/06

Efficacy and Safety of Celecoxib Versus Ibuprofen in the Treatment of Osteoarthritis of the Knee (United States)

Phase: N/A Priority: Normal

NCT ID: NCT00620867 Org: User:

Start: 10/31/02 End: 03/31/03 Due: 03/31/04

Non Interventional Study In Bipolar Disorder And Schizophrenia With Zeldox

Phase: N/A Priority: Normal

NCT ID: NCT00538629 Org: User:

Start: 10/16/07 End: 04/30/08 Due: 04/30/09

Naturalistic Safety Registry Of Celecoxib (CELEBREX(R)) And NSAIDs In Juvenile Idiopathic Arthritis

Phase: N/A Priority: Normal

NCT ID: NCT00688545 Org: User:

Start: 04/30/09 End: 01/31/12 Due: 01/31/13

Double Blind Atorvastatin Amlodipine Study

Phase: N/A Priority: Normal

NCT ID: NCT00159718 Org: User:

Start: 07/31/01 End: 01/31/07 Due: 01/31/08

Atorvastatin Effectiveness and Safety in Cardiology Patients in Real World Setting

Phase: N/A Priority: Normal

NCT ID: NCT02565615 Org: User:

Start: 06/22/16 End: 08/31/18 Due: 08/31/19

Clinical Effect Of Cross Titration Of Antipsychotics With Ziprasidone In Schizophrenia Or Schizoaffective Disorder

Phase: N/A Priority: Normal

NCT ID: NCT00137020 Org: User:

Start: 11/30/04 End: 04/30/06 Due: 04/30/07

Selara Drug Use Investigation (Regulatory Post Marketing Commitment Plan)

Phase: N/A Priority: Normal

NCT ID: NCT00749775 Org: User:

Start: 06/30/08 End: 12/31/12 Due: 12/31/13

Caduet in an Untreated Subject Population

Phase: N/A Priority: Normal

NCT ID: NCT00332761 Org: User:

Start: 06/30/06 End: 09/30/07 Due: 09/30/08

Efficacy and Safety of Eletriptan for the Treatment of Migraine in Patients Not Satisfied With Rizatriptan Therapy

Phase: N/A Priority: Normal

NCT ID: NCT00632385 Org: User:

Start: 01/31/03 End: 08/31/03 Due: 08/31/04

Surgical Pain After Inguinal Hernia Repair (SPAIHR)

Phase: N/A Priority: Normal

NCT ID: NCT00551135 Org: User:

Start: 01/31/08 End: 09/30/09 Due: 09/30/10

A Study to Evaluate the Efficacy of a Counselling and Advisory Care for Health (COACH) Program in Dyslipidemic Patients.

Phase: N/A Priority: Normal

NCT ID: NCT00708370 Org: User:

Start: 08/31/08 End: 06/30/10 Due: 06/30/11

Kahn Study; Investigation Of The Efficacy Of Ziprasidone Versus Olanzapine In The Management Of Recent-Onset Psychosis; A Flexible-Dose, Parallel Group, Double-Blind Study

Phase: N/A Priority: Normal

NCT ID: NCT00145444 Org: User:

Start: 03/31/03 End: 11/30/05 Due: 11/30/06

A Study Comparing the Efficacy and Safety of Ziprasidone and Aripiprazole for the Treatment fo Schizophrenia or Schizoaffective Disorder in Hospitalized Patients

Phase: N/A Priority: Normal

NCT ID: NCT00634348 Org: User:

Start: 04/30/04 End: 03/31/05 Due: 03/31/06

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Special Investigation For Long-Term Use Of Sildenafil (Regulatory Post Marketing Commitment Plan)	NCT00666198	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2008-05-31	2015-06-30	2016-06-30	-	-	2025-07-14
A Post Marketing Surveillance Study Of Doxazosin Mesylate GITS Among Filipino Patients With Benign Prostatic Hyperplasia (BPH)	NCT01003886	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2009-05-31	2011-01-31	2012-01-31	-	-	2025-07-14
Safety, Tolerability, and Pharmacokinetic Study of Pregabalin in Pediatric Patients With Partial Onset Seizures	NCT00437281	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2007-04-30	2012-11-30	2013-11-30	-	-	2025-07-14
Effectiveness Of A Program That Includes Counseling And Patient Support On Adherence To Treatment With Lipitor	NCT01078285	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2010-03-31	2011-11-30	2012-11-30	-	-	2025-07-14
Evaluation Of Sperm Production With Healthy Male Volunteers Receiving Lyrica Or Placebo	NCT00631696	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2008-02-29	2012-02-29	2013-02-28	-	-	2025-07-14
Safety And Efficacy Of Sildenafil In Children With Pulmonary Arterial Hypertension	NCT01642407	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2012-08-24	2018-03-12	2019-03-12	-	-	2025-07-14
One-Year Trial of Oral Ziprasidone in Bipolar Patients With Metabolic Syndrome	NCT01113541	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2010-07-31	2011-02-28	2012-02-28	-	-	2025-07-14
Examination of Pregabalin Access for Treatment of Indicated Pain Disorders: the ExPAND Study	NCT01280747	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2011-01-31	2012-04-30	2013-04-30	-	-	2025-07-14
A Post Marketing Surveillance Study On Pregabalin (Lyrica) On Efficacy, Safety And Tolerability Of Pregabalin	NCT00892008	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2006-09-30	2008-08-31	2009-08-31	-	-	2025-07-14
Comparison of Pregabalin Versus Venlafaxine XR and Placebo in the Treatment of Generalized Anxiety Disorder	NCT00151450	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2005-03-31	2006-11-30	2007-11-30	-	-	2025-07-14
A Study Of Sertraline Compared With Paroxetine In The Treatment Of Panic Disorder	NCT00677352	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2008-05-31	2010-02-28	2011-02-28	-	-	2025-07-14
A Study of the Safety and Tolerability of Oral Ziprasidone in Children and Teens With Psychotic Disorders	NCT00650611	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2003-12-31	2005-03-31	2006-03-31	-	-	2025-07-14
Efficacy and Safety of Celecoxib Versus Ibuprofen in the Treatment of Osteoarthritis of the Knee (United States)	NCT00620867	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2002-10-31	2003-03-31	2004-03-31	-	-	2025-07-14
Non Interventional Study In Bipolar Disorder And Schizophrenia With Zeldox	NCT00538629	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2007-10-16	2008-04-30	2009-04-30	-	-	2025-07-14
Naturalistic Safety Registry Of Celecoxib (CELEBREX(R)) And NSAIDs In Juvenile Idiopathic Arthritis	NCT00688545	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2009-04-30	2012-01-31	2013-01-31	-	-	2025-07-14
Double Blind Atorvastatin Amlodipine Study	NCT00159718	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2001-07-31	2007-01-31	2008-01-31	-	-	2025-07-14
Atorvastatin Effectiveness and Safety in Cardiology Patients in Real World Setting	NCT02565615	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2016-06-22	2018-08-31	2019-08-31	-	-	2025-07-14
Clinical Effect Of Cross Titration Of Antipsychotics With Ziprasidone In Schizophrenia Or Schizoaffective Disorder	NCT00137020	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2004-11-30	2006-04-30	2007-04-30	-	-	2025-07-14
Selara Drug Use Investigation (Regulatory Post Marketing Commitment Plan)	NCT00749775	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2008-06-30	2012-12-31	2013-12-31	-	-	2025-07-14
Caduet in an Untreated Subject Population	NCT00332761	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2006-06-30	2007-09-30	2008-09-30	-	-	2025-07-14
Efficacy and Safety of Eletriptan for the Treatment of Migraine in Patients Not Satisfied With Rizatriptan Therapy	NCT00632385	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2003-01-31	2003-08-31	2004-08-31	-	-	2025-07-14
Surgical Pain After Inguinal Hernia Repair (SPAIHR)	NCT00551135	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2008-01-31	2009-09-30	2010-09-30	-	-	2025-07-14
A Study to Evaluate the Efficacy of a Counselling and Advisory Care for Health (COACH) Program in Dyslipidemic Patients.	NCT00708370	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2008-08-31	2010-06-30	2011-06-30	-	-	2025-07-14
Kahn Study; Investigation Of The Efficacy Of Ziprasidone Versus Olanzapine In The Management Of Recent-Onset Psychosis; A Flexible-Dose, Parallel Group, Double-Blind Study	NCT00145444	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2003-03-31	2005-11-30	2006-11-30	-	-	2025-07-14
A Study Comparing the Efficacy and Safety of Ziprasidone and Aripiprazole for the Treatment fo Schizophrenia or Schizoaffective Disorder in Hospitalized Patients	NCT00634348	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	user2@example.com	None	2004-04-30	2005-03-31	2006-03-31	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance